Haemonetics Receives FDA Approval To Expand Labeling For VASCADE MVP XL Venous Vascular Closure System

Haemonetics Corporation has received FDA approval to expand the labeling for its VASCADE MVP XL venous vascular closure system, now including procedures with 10-14F inner diameter and up to 17F outer diameter procedural sheaths. This expansion allows the system to be used with larger sheaths in advanced technologies for pulsed field ablation and left atrial appendage closure, aimed at treating atrial fibrillation.